ANDOVER, Mass., Sept. 26 /PRNewswire/ -- Sentillion, Inc., the leading provider of identity and access management (IAM) solutions for the healthcare industry, announced today that it has received its first patent (6,941,313) from the United States Patent and Trademark Office. The patent is for a unique context management technology with advanced audit capabilities, upon which the company’s Vergence(R) Privacy Auditor(TM) product is based.
“The granting of this patent demonstrates our technology leadership, reflects our history of innovation and protects our intellectual property,” said Robert Seliger, CEO of Sentillion. “We are excited that this first patent has been formally issued and look forward to announcing additional patent awards in the upcoming months as our robust patent cache continues to mature. Our 127,000 live users and our partners can have confidence that their reliance upon, and trust in, Sentillion’s solutions is well placed.”
Vergence Privacy Auditor enables healthcare organizations to protect confidential patient information from inappropriate access. Privacy Auditor tracks application context events for all Vergence-aware application across the enterprise, including all instances when the user logs on, selects a patient of interest and logs off. The result is the application access paths of individual users can be monitored in order to understand who viewed what patient records, when, where, and how often.
“Using Privacy Auditor, healthcare administrators and IT professionals can easily produce patient record access reports from a single, consolidated audit log,” said David Fusari, Sentillion’s chief technology officer, and co- inventor of the audit invention. “Healthcare organizations are able to meet Health Insurance Portability and Accountability Act (HIPAA) privacy and security mandates while ensuring that confidential patient information stays confidential and security breaches are rapidly discovered.”
“This patent not only validates a critical underpinning of our Vergence identity and access management solution, but also reflects our steadfast commitment to protecting our growing foundation of intellectual property,” said Holly Kimball, attorney for Sentillion. “The safeguarding of our intellectual property is essential in continuing to differentiate ourselves from our competitors while delivering the highest quality solutions to our healthcare customers.”
Sentillion’s identity and access management products help healthcare provider organizations meet their urgent need for patient safety and privacy, streamlined workflows, regulatory compliance, and protection of data and information sources. Sentillion’s Vergence product suite enables organizations to know who their users are -- identity management -- and to help them be productive while ensuring system security and guarding patient confidentiality -- access management.
About Sentillion
Sentillion provides identity and access management solutions to the healthcare industry. Sentillion’s Vergence(R) product suite enables healthcare organizations to know who their users are, help them be productive, guard their systems and protect their patients. The Vergence product suite includes user provisioning, strong authentication, single sign-on, clinical context management and privacy management. Sentillion was named the leading vendor for healthcare single sign-on for three consecutive years by IDC Research and was the recipient of the Frost & Sullivan 2004 Customer Value Enhancement Award in Healthcare. Sentillion is a privately held company headquartered in Andover, Mass. For more information, visit Sentillion at http://www.sentillion.com.
Sentillion, Inc.
CONTACT: Jennifer Haas of Sentillion, +1-978-749-0022, ext. 262,jennifer.haas@sentillion.com; or Palmer Reuther of Racepoint Group,+1-781-487-4606, preuther@racepointgroup.com
Web site: http://www.sentillion.com//
